AIS
UTHR icon

AlphaOne Investment Services’s United Therapeutics UTHR Stock Holding History

AlphaOne Investment Services’s Portfolio UTHR Stock Details UTHR Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2014
Q1 		– Sell
-15,213
Closed -$1.72M – 162
2013
Q4 		$1.72M Buy
15,213
+8,450
+125% +$762K 0.37% 97
2013
Q3 		$533K Hold
6,763
– – 0.14% 135
2013
Q2 		$445K Buy
+6,763
New +$436K 0.12% 150

Other funds holding UTHR

BNP Paribas Financial Markets
BNP Paribas Financial Markets Paris, France $206B AUM 31.61% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
AL
AJO LP Philadelphia, Pennsylvania $199M AUM 109.68% 1-Year Est. Return
BFA
BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return
Deutsche Bank
Deutsche Bank Frankfurt Am Main Ge, Germany $303B AUM 30.15% 1-Year Est. Return
Acadian Asset Management
Acadian Asset Management Boston, Massachusetts $70.5B AUM 36% 1-Year Est. Return
BIT
BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return
LSV Asset Management
LSV Asset Management Chicago, Illinois $46.4B AUM 27.74% 1-Year Est. Return
BA
BlackRock Advisors Wilmington, Delaware $98.8B AUM 15.8% 1-Year Est. Return

AlphaOne Investment Services's UTHR Position: Q1 2014 in Review

AlphaOne Investment Services sold out of United Therapeutics (UTHR) in Q1 2014, closing a stake of 15,213 shares — an estimated $1.72M sold.

AlphaOne Investment Services first reported a position in UTHR in Q2 2013 and held it in 3 quarters. The position peaked at $1.72M in Q4 2013. 308 funds tracked by Wall St. Rank hold UTHR as of Q1 2014.

  • AlphaOne Investment Services reported no remaining United Therapeutics position as of Q1 2014 after selling out during the quarter.
  • AlphaOne Investment Services sold 15,213 United Therapeutics shares in Q1 2014, an estimated $1.72M.
  • AlphaOne Investment Services first reported a position in United Therapeutics in Q2 2013 and held it in 3 quarters.
  • AlphaOne Investment Services's United Therapeutics position peaked at $1.72M in Q4 2013.
  • 308 funds tracked by Wall St. Rank held United Therapeutics as of Q1 2014.

Based on AlphaOne Investment Services's 13F filing for Q1 2014, filed 15 May 2014.